BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4064588)

  • 1. C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.
    Tishler M; Caspi D; Yaron M
    Clin Rheumatol; 1985 Sep; 4(3):321-4. PubMed ID: 4064588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.
    Walsh L; Davies P; McConkey B
    Ann Rheum Dis; 1979 Aug; 38(4):362-3. PubMed ID: 496450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
    Situnayake RD; McConkey B
    J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
    Dawes PT; Fowler PD; Clarke S; Fisher J; Lawton A; Shadforth MF
    Br J Rheumatol; 1986 Feb; 25(1):44-9. PubMed ID: 3942847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study).
    Migliore A; Bizzi E; Massafra U; Vacca F; Martin Martin LS; Ferlito C; Podestà E; Granata M; Laganà B
    Int J Immunopathol Pharmacol; 2010; 23(3):783-90. PubMed ID: 20943048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anemia.
    Sany J
    J Rheumatol Suppl; 1978; 4():43-7. PubMed ID: 366142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of inflammatory cytokines in patients with rheumatoid arthritis].
    Kang SY; Kim MH; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):301-6. PubMed ID: 20603592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S; Solomon G
    Bull Hosp Jt Dis Orthop Inst; 1990; 50(2):160-8. PubMed ID: 2175662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria in patients with rheumatoid arthritis.
    Pedersen LM; Nordin H; Svensson B; Bliddal H
    Ann Rheum Dis; 1995 Mar; 54(3):189-92. PubMed ID: 7748016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.
    McConkey B; Davies P; Crockson RA; Crockson AP; Butler M; Constable TJ; Amos RS
    Ann Rheum Dis; 1979 Apr; 38(2):141-4. PubMed ID: 109055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical parameters in the assessment of anti-inflammatory drugs--a review.
    Laurent MR; Panayi GS
    Agents Actions Suppl; 1980; 7():310-7. PubMed ID: 7018201
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients.
    Rau R; Herborn G; Menninger H; Blechschmidt J
    Br J Rheumatol; 1997 Mar; 36(3):345-52. PubMed ID: 9133967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
    Dhaon P; Das SK; Srivastava R; Dhakad U
    Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.